Free Shipping on Orders Over $149 — Lab-Tested 99%+ Purity — USA Shipped

CJC-1295 + Ipamorelin 10mg - Research Peptide
Body Composition 10mg

CJC-1295 + Ipamorelin

$89.00 In Stock

Synergistic GH secretagogue blend for body composition research.

≥98%
HPLC Purity
COA
Included
USA
Based Supplier

Description

Synergistic GH secretagogue blend for body composition research.

CJC-1295 + Ipamorelin is a dual-peptide formulation combining a growth hormone-releasing hormone (GHRH) analogue with a selective growth hormone secretagogue receptor (GHSR/ghrelin receptor) agonist. These two peptides operate through complementary mechanisms: CJC-1295 (without DAC) stimulates GH release by binding GHRH receptors on pituitary somatotrophs and amplifying the baseline GH pulse, while ipamorelin activates the ghrelin receptor to initiate a separate GH release signal. When administered together, research indicates a synergistic amplification of GH pulsatility that exceeds the additive effects of either peptide alone. This synergy was characterized in studies examining GHRH-GHRP co-administration, where combined protocols produced GH peaks 2-3 times greater than single-agent protocols (Bowers et al., Endocrinology). Ipamorelin is distinguished among ghrelin mimetics by its high selectivity for GH release without significantly elevating cortisol, prolactin, or ACTH levels, as demonstrated in clinical studies (Raun et al., European Journal of Endocrinology, 1998). CJC-1295 without DAC has a half-life of approximately 30 minutes, producing acute GH pulses rather than sustained elevation. Compared to GHRP-6, which broadly activates ghrelin receptors causing appetite stimulation, ipamorelin offers cleaner GH release profiles. Store lyophilized powder at -20C; reconstitute with bacteriostatic water and refrigerate at 2-8C for up to 28 days. This combination is widely studied by endocrinology research labs, sports medicine institutions, and body composition research centers investigating optimized GH secretagogue protocols.

This product is supplied as a lyophilized powder and is intended for laboratory and research use only. Not for human consumption. Each vial contains 10mg of research-grade material.

Research Applications

  • Growth hormone pulsatility optimization
  • IGF-1 level modulation
  • Lean mass preservation studies
  • Metabolic anabolic balance research

Specifications

Size
10mg
Purity
≥98% (HPLC)
Form
Lyophilized Powder

Storage & Handling

  • Long-term storage: -20°C in a sealed, light-protected container
  • Short-term storage: 2-8°C (refrigerated) for up to 30 days
  • Reconstituted: Store at 2-8°C and use within 30 days
  • Avoid: Repeated freeze-thaw cycles, direct sunlight, and moisture exposure
  • Reconstitution: Use bacteriostatic water or sterile water for injection

Frequently Asked Questions

What is CJC-1295 + Ipamorelin and how does it work?
This combination pairs two distinct growth hormone secretagogues that work through complementary mechanisms. CJC-1295 (without DAC) is a modified GHRH analogue that stimulates GH release from pituitary somatotrophs via the GHRH receptor. Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist. Together, they amplify GH pulsatility through dual-pathway stimulation while maintaining selectivity — ipamorelin does not significantly affect cortisol or prolactin levels.
What research has been done on CJC-1295 + Ipamorelin?
CJC-1295 research published in the Journal of Clinical Endocrinology & Metabolism demonstrated sustained GH and IGF-1 elevation with a favorable safety profile. Ipamorelin studies (European Journal of Endocrinology) showed selective GH release without significant hunger, cortisol, or prolactin side effects. The combination has been studied in preclinical models for synergistic GH amplification, with results suggesting greater GH AUC than either peptide alone.
How does CJC-1295 + Ipamorelin compare to GHRP-6?
The key advantage of ipamorelin over GHRP-6 is selectivity. GHRP-6 activates ghrelin receptors broadly, causing significant increases in appetite, cortisol, and prolactin. Ipamorelin is among the most selective GH secretagogues, stimulating GH release with minimal impact on other hormones. When combined with CJC-1295, it provides a cleaner research model for studying GH-specific effects without confounding hormonal variables.
What is the recommended reconstitution protocol for CJC-1295 + Ipamorelin?
For this 10mg vial (5mg CJC-1295 + 5mg Ipamorelin), reconstitute with 2mL of bacteriostatic water for a total concentration of 5mg/mL (2.5mg/mL of each peptide). Allow 3-5 minutes for full dissolution. Add water along the vial wall without agitation. Store reconstituted solution at 2-8°C and use within 30 days.
What purity testing is performed on CJC-1295 + Ipamorelin?
Both CJC-1295 and Ipamorelin are individually HPLC-tested to meet the minimum 98% purity standard before blending. The combined formulation undergoes additional HPLC analysis to verify correct ratios and overall purity. Mass spectrometry confirms molecular identity of both peptides. Endotoxin, sterility, and residual solvent testing is performed on the final product, with a comprehensive COA included.

Related Products

Ipamorelin 10mg
10mg In Stock

Ipamorelin

Highly selective synthetic pentapeptide GH secretagogue for research.

$79.00
CJC-1295 (without DAC) 10mg
10mg In Stock

CJC-1295 (without DAC)

Modified GHRH analogue for growth hormone release research.

$79.00
CJC-1295 (with DAC) 5mg
5mg In Stock

CJC-1295 (with DAC)

Extended half-life GHRH analogue with Drug Affinity Complex for sustained GH research.

$95.00

Research Use Only. This product is not intended for human consumption, therapeutic use, or diagnostic purposes. All peptides sold by Elyte Peptides are strictly for in-vitro research and laboratory use. By purchasing, you agree to use this product in compliance with all applicable laws and regulations.